Mali makes history with Hybrid Malaria vaccine strategy amid Dengue outbreak
This week, Mali has taken center stage in Africa’s public health landscape with a world-first malaria vaccination approach, even as health authorities sound the alarm over a worsening dengue fever situation.
The Malian Ministry of Health has pioneered an innovative dual vaccination strategy against malaria that combines routine childhood immunization with seasonal preventive dosing.
This hybrid model, announced during World Malaria Day observances, targets children aged 5-36 months through age-based vaccinations while adding pre-transmission boosters ahead of peak infection periods.
The R21/Matrix-M vaccine will be deployed across 19 high-transmission districts in a country that reported 8.15 million malaria cases in 2023, representing 3.1% of the global burden according to WHO data.
However, this public health achievement comes alongside concerning dengue fever developments. Health Minister Colonel Assa Badiallo Touré has warned citizens about rising cases of the mosquito-borne viral illness, which causes debilitating symptoms including high fever, severe joint pain, and characteristic skin rashes.
In response to the outbreak, Transitional President Colonel Assima Goïta has issued urgent calls for enhanced preventive measures, emphasizing the need for prompt medical attention when symptoms appear and comprehensive community efforts to eliminate mosquito breeding grounds.
Titi KEITA
